TrialTrials2014

The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial.

Sheraz A Nazir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.